Literature DB >> 22955297

[Early diagnosis of hepatitis C transmission after needlestick injury].

H Himmelreich1, C M Sarrazin, C Stephan, H F Rabenau, I Marzi, S Wicker.   

Abstract

Occupational transmission of hepatitis C (HCV) is rare but has been repeatedly described in the published literature. Early diagnosis and therapy of acute hepatitis C is associated with an excellent chance of permanent HCV elimination. The majority of chronic HCV infections, however, lead to a slowly progressive hepatitis with associated morbidity and risk of liver cirrhosis. For this reason the need for antiviral therapy has to be evaluated immediately.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 22955297     DOI: 10.1007/s00113-012-2261-5

Source DB:  PubMed          Journal:  Unfallchirurg        ISSN: 0177-5537            Impact factor:   1.000


  7 in total

1.  New HIV diagnosis after occupational exposure screening: the importance of reporting needlestick injuries.

Authors:  L M Upjohn; R L Stuart; T M Korman; I J Woolley
Journal:  Intern Med J       Date:  2012-02       Impact factor: 2.048

Review 2.  [Comorbidity: anemia and heart failure].

Authors:  F Mahfoud; I Kindermann; M Kindermann; C Ukena; M Böhm
Journal:  Dtsch Med Wochenschr       Date:  2009-04-07       Impact factor: 0.628

3.  SHEA guideline for management of healthcare workers who are infected with hepatitis B virus, hepatitis C virus, and/or human immunodeficiency virus.

Authors:  David K Henderson; Louise Dembry; Neil O Fishman; Christine Grady; Tammy Lundstrom; Tara N Palmore; Kent A Sepkowitz; David J Weber
Journal:  Infect Control Hosp Epidemiol       Date:  2010-03       Impact factor: 3.254

4.  [Prophylaxis, diagnosis and therapy of hepatitis C virus (HCV) infection: the German guidelines on the management of HCV infection].

Authors:  C Sarrazin; T Berg; R S Ross; P Schirmacher; H Wedemeyer; U Neumann; H H Schmidt; U Spengler; S Wirth; H H Kessler; M Peck-Radosavljevic; P Ferenci; W Vogel; D Moradpour; M Heim; M Cornberg; U Protzer; M P Manns; W E Fleig; M M Dollinger; S Zeuzem
Journal:  Z Gastroenterol       Date:  2010-01-29       Impact factor: 2.000

5.  Case report: risk of virus infection after accidental blood inoculation from a multi-infected AIDS patient.

Authors:  Annemarie Berger; M Stürmer; H W Doerr
Journal:  J Med Virol       Date:  2012-06       Impact factor: 2.327

Review 6.  [Injuries from needles contaminated with hepatitis C virus: how high is the risk of seroconversion for medical personnel really?].

Authors:  A Kubitschke; C Bader; H L Tillmann; M P Manns; S Kuhn; H Wedemeyer
Journal:  Internist (Berl)       Date:  2007-10       Impact factor: 0.743

7.  [Postexposure prevention after occupational exposure to HBV, HCV and HIV].

Authors:  U Sarrazin; R Brodt; C Sarrazin; S Zeuzem
Journal:  Unfallchirurg       Date:  2004-02       Impact factor: 1.000

  7 in total
  5 in total

1.  [HIV prophylaxis kits. A concept for emergency treatment in the context of postexposure prophylaxis].

Authors:  S Wicker; F Walcher; S Wutzler; I Marzi; C Stephan
Journal:  Chirurg       Date:  2014-01       Impact factor: 0.955

2.  The management of needlestick injuries.

Authors:  Heiko Himmelreich; Holger F Rabenau; Matthias Rindermann; Christoph Stephan; Markus Bickel; Ingo Marzi; Sabine Wicker
Journal:  Dtsch Arztebl Int       Date:  2013-02-01       Impact factor: 5.594

3.  Best practice for needlestick injuries.

Authors:  S Wicker; F Walcher; S Wutzler; C Stephan; I Marzi
Journal:  Eur J Trauma Emerg Surg       Date:  2014-01-31       Impact factor: 3.693

4.  [Prevalence of blood-borne pathogens among 275 trauma patients : A prospective observational study].

Authors:  S Wicker; H F Rabenau; B Scheller; I Marzi; S Wutzler
Journal:  Unfallchirurg       Date:  2016-08       Impact factor: 1.000

5.  Seroconversion after needlestick injuries - analyses of statutory accident insurance claims in Germany.

Authors:  Madeleine Dulon; Dana Wendeler; Albert Nienhaus
Journal:  GMS Hyg Infect Control       Date:  2018-07-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.